Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - July 2010

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for July 2010 (PDF).

This issue contains drug safety advice relating to the risk of accidental overdose with intravenous paracetamol (Perfalgan®). While this product is not likely to be widely used in primary care, clinicians should be aware of the risks and take precautions if prescribing this item.

This issue also informs readers that patient information about the Yellow Card Scheme is now available in 11 languages other than English.

The Stop Press section contains a reminder that orciprenaline sulphate (Alupent®) will be withdrawn at the end of September 2010. A recent review found that this product to be less effective and associated with a higher incidence of side effects when compared to more selective beta2-agonists.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update - July 2010' on Email Share 'Drug Safety Update - July 2010' on Delicious Share 'Drug Safety Update - July 2010' on Digg Share 'Drug Safety Update - July 2010' on Facebook Share 'Drug Safety Update - July 2010' on Google+ Share 'Drug Safety Update - July 2010' on reddit Share 'Drug Safety Update - July 2010' on StumbleUpon Share 'Drug Safety Update - July 2010' on Twitter

atomic-wealth

No Comments to “Drug Safety Update - July 2010”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,612 spam comments.

atomic-wealth
fond-illness
summer